The complex development of craniofacial skeletal structures and improve treatments for congenital craniofacial malformations.
23andMe wins FDA clearance to test for expanded set of BRCA cancer risk variants
Dive Brief: The U.S. Food and Drug Administration cleared 23andMe on Thursday to report another 41 BRCA1 and BRCA2 gene variants in its cancer risk test.